Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiora Pharmaceuticals (KPRX) Revenue (2016 - 2024)

Kiora Pharmaceuticals (KPRX) has disclosed Revenue for 8 consecutive years, with $20000.0 as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Revenue changed N/A year-over-year to $20000.0, compared with a TTM value of $20000.0 through Mar 2025, down 99.88%, and an annual FY2024 reading of $16.0 million, changed N/A over the prior year.
  • Revenue was $20000.0 for Q2 2024 at Kiora Pharmaceuticals, down from $16.0 million in the prior quarter.
  • Across five years, Revenue topped out at $16.0 million in Q1 2024 and bottomed at -$4132.0 in Q4 2021.
  • Average Revenue over 3 years is $2.7 million, with a median of $5686.5 recorded in 2020.
  • Peak annual rise in Revenue hit 134.26% in 2021, while the deepest fall reached 134.26% in 2021.
  • Year by year, Revenue stood at $12059.0 in 2020, then crashed by 134.26% to -$4132.0 in 2021, then soared by 584.03% to $20000.0 in 2024.
  • Business Quant data shows Revenue for KPRX at $20000.0 in Q2 2024, $16.0 million in Q1 2024, and -$4132.0 in Q4 2021.